H.I.V. Research Networks Face Uncertain Future Amid Funding Delays

The New York Times – Business:

The networks also study treatments and preventions for other infectious diseases and were instrumental in testing the Covid vaccine.

This post first appeared in The New York Times – Business. Read the original article.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *